Recommendations for Titration and Administration of Oral Semaglutide for the Treatment of Type 2 Diabetes during Ramadan
Background: Injectable glucagon-like peptide-1 receptor agonists (GLP-1RAs) are proven to be well tolerated and efficacious in people with type 2 diabetes mellitus (T2DM) fasting during Ramadan. The first oral GLP-1RA semaglutide, also indicated for the treatment of T2DM, has specific dosing instruc...
Published in: | Dubai Diabetes and Endocrinology |
---|---|
Main Author: | |
Format: | Review |
Language: | English |
Published: |
S. Karger AG
2022
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85198014844&doi=10.1159%2f000527475&partnerID=40&md5=ae23fc9ac69a9da02608be1dbf55cbda |